Skip to main content
Clinical Trials/NCT05798975
NCT05798975
Completed
Not Applicable

Analysis of Heart Rate Variability After One Session of Aerobic or Resistance Physical Exercise in Controlled Hypertensive Individuals: Randomized Clinical Trial

Instituto de Cardiologia do Rio Grande do Sul1 site in 1 country36 target enrollmentApril 1, 2022
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Instituto de Cardiologia do Rio Grande do Sul
Enrollment
36
Locations
1
Primary Endpoint
Heart Rate Variability.
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

Systemic arterial hypertension (SAH) is a multifactorial clinical condition, characterized by sustained elevation of blood pressure levels, contributing to 50% of deaths from cardiovascular disease. The Autonomic Nervous System (ANS) plays a fundamental role in the regulation of Blood Pressure (BP) and is closely associated with Heart Rate (HR). HR changes are called Heart Rate Variability (HRV). In individuals with SAH, HRV indices are reduced compared to normotensive individuals, showing changes in autonomic modulation, thus increasing the risk for cardiovascular events. The objective of this study will be to analyze the Heart Rate Variability in individuals with controlled SAH after a session of aerobic (EA) or resistance (RE) physical exercise.

Detailed Description

Controlled hypertensive individuals aged between 30 and 59 years will be selected, for convenience, who use the services of the Instituto de Cardiologia do Rio Grande do Sul. Volunteers will be randomly assigned to an EA session (40 minutes on cycle ergometer, 60% of heart rate reserve) or RE (2 exercises for lower limbs and 2 for upper limbs with 4 sets of 12 repetitions at 60% 1-RM) or control group without exercise. HRV data will be collected by ECG (Wincardio USB - Version 11.1.0.0, MICROMED Biotecnologia Ltda, Brasília - DF - Brazil) during 10 minutes before the exercise session, 10 minutes after the exercise session, 1h and 2h post-session . It is expected to estimate results that may demonstrate clarifications about the impact of a physical exercise session on HRV in controlled hypertensive individuals.

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
November 30, 2024
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Instituto de Cardiologia do Rio Grande do Sul
Responsible Party
Principal Investigator
Principal Investigator

Diego Silveira da Silva

physical education professor.

Instituto de Cardiologia do Rio Grande do Sul

Eligibility Criteria

Inclusion Criteria

  • Controlled Systemic Alterial Hypertension

Exclusion Criteria

  • Diabetes mellitus;
  • heart failure;
  • coronary artery disease;
  • chronic renal failure;
  • body mass index (BMI) ≥ 35 kg/m2;
  • individuals with injuries to the upper and lower limbs that make the exercise protocol impossible;
  • not using antihypertensive medication and using beta-blocker and/or alpha-blocker medication.

Outcomes

Primary Outcomes

Heart Rate Variability.

Time Frame: 4 hours

Analysis of heart rate variability with Wincardio Digital ECG.

Study Sites (1)

Loading locations...

Similar Trials